(0.63%) 5 114.50 points
(0.12%) 38 333 points
(0.86%) 17 719 points
(0.19%) $83.73
(-3.36%) $1.583
(0.90%) $2 363.60
(1.32%) $27.72
(0.54%) $925.50
(-0.05%) $0.931
(0.26%) $10.98
(-0.04%) $0.799
(-0.04%) $92.13
@ $52.08
Issued: 15 Apr 2024 @ 14:17
Return: -14.70%
Previous signal: Apr 15 - 13:41
Previous signal:
Return: -1.02 %
Live Chart Being Loaded With Signals
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally...
Stats | |
---|---|
Today's Volume | 1.85M |
Average Volume | 971 885 |
Market Cap | 8.08B |
EPS | $0 ( 2024-03-11 ) |
Next earnings date | ( $-0.240 ) 2024-05-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -15.11 |
ATR14 | $0.0510 (0.11%) |
Volume Correlation
Legend Biotech Corp Correlation
10 Most Positive Correlations | |
---|---|
AQST | 0.804 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Legend Biotech Corp Correlation - Currency/Commodity
Legend Biotech Corp Financials
Annual | 2023 |
Revenue: | $285.14M |
Gross Profit: | $120.48M (42.25 %) |
EPS: | $-2.94 |
FY | 2023 |
Revenue: | $285.14M |
Gross Profit: | $120.48M (42.25 %) |
EPS: | $-2.94 |
FY | 2022 |
Revenue: | $117.01M |
Gross Profit: | $51.64M (44.14 %) |
EPS: | $-2.81 |
FY | 2021 |
Revenue: | $89.79M |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-2.74 |
Financial Reports:
No articles found.
Legend Biotech Corp
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma (MM), as well as a comparison of the treatment with standard triplet therapy in revlimid-refractory multiple myeloma. The company also has a portfolio of earlier-stage autologous product candidates, which are in Phase I clinical trials for the treatment of gastric cancer and T cell lymphoma. In addition, it is developing CAR-T product candidates targeting CD20/CD22/CD19 for the treatment of non-hodgkins lymphoma, diffuse large B-cell lymphoma, and acute lymphoblastic leukemia. Further, the company has product candidates in early preclinical and clinical development for the treatment of solid tumors as well as infectious diseases. It has collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of ciltacabtagene autoleucel. Legend Biotech Corporation was founded in 2014 and is based in Somerset, New Jersey. Legend Biotech Corporation is a subsidiary of Genscript Biotech Corporation.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators